This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Cz Biohub Sf, LLC., Mayo Foundation for Medical Education and Research, University of California. Active years: 2025.
Company Filing History:
1 out of 23 
1 out of 1,808 
1 out of 16,008 
Years Active: 2025
Title: Caleigh Mandel-Brehm: Innovator in Cancer Biomarkers
Introduction
Caleigh Mandel-Brehm is a notable inventor based in Oakland, CA (US). She has made significant contributions to the field of cancer research, particularly in the detection of biomarkers associated with testicular cancer. Her innovative work has the potential to improve diagnostic methods and treatment options for patients.
Latest Patents
Caleigh holds a patent titled "Autoantibodies as biomarker of paraneoplastic encephalitis associated with testicular cancer." This patent describes methods and compositions for detecting the presence of a Kelch-like protein 11 autoantibody in a biological sample. Additionally, it provides methods for treating subjects with testicular cancer or a premalignant condition and paraneoplastic encephalomyelitis. She has 1 patent to her name.
Career Highlights
Throughout her career, Caleigh has worked with prominent organizations such as the Cz Biohub and the University of California. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Caleigh has collaborated with notable individuals such as Joseph L. DeRisi and Michael R. Wilson. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Caleigh Mandel-Brehm is a pioneering inventor whose work in cancer biomarkers is paving the way for advancements in medical diagnostics and treatment. Her contributions are invaluable to the ongoing fight against cancer.